Jacques, C.; Marchand, F.; Chatelais, M.; Brulefert, A.; Floris, I.
Understanding the Mode of Action of a Micro-Immunotherapy Formulation: Pre-Clinical Evidence from the Study of 2LEBV® Active Ingredients. Life 2024, 14, 102.
https://doi.org/10.3390/life14010102
AMA Style
Jacques C, Marchand F, Chatelais M, Brulefert A, Floris I.
Understanding the Mode of Action of a Micro-Immunotherapy Formulation: Pre-Clinical Evidence from the Study of 2LEBV® Active Ingredients. Life. 2024; 14(1):102.
https://doi.org/10.3390/life14010102
Chicago/Turabian Style
Jacques, Camille, Flora Marchand, Mathias Chatelais, Adrien Brulefert, and Ilaria Floris.
2024. "Understanding the Mode of Action of a Micro-Immunotherapy Formulation: Pre-Clinical Evidence from the Study of 2LEBV® Active Ingredients" Life 14, no. 1: 102.
https://doi.org/10.3390/life14010102
APA Style
Jacques, C., Marchand, F., Chatelais, M., Brulefert, A., & Floris, I.
(2024). Understanding the Mode of Action of a Micro-Immunotherapy Formulation: Pre-Clinical Evidence from the Study of 2LEBV® Active Ingredients. Life, 14(1), 102.
https://doi.org/10.3390/life14010102